Summary of UAEM Presentation to UC TTAC

On March 12, 2009, UAEM members from UCLA, UC Hastings, UCSF and UC Berkeley met with the system-wide Technology Transfer Advisory Committee and presented UAEM’s Global Access License Framework. UAEM explained its origins at Yale, and the effect of its successes there to lower the price of stavudine (d4t) by 96% for HIV-positive patients in South Africa.

Seeking to turn that single-compound policy into a system-wide reality, UAEM motivated a proposal to study global access principles that the UC could make its own. Informed by the Stanford Nine Points and drawing on UC experts in medicine, law, policy, and technology transfer, the process the TTAC currently considers would allow for maximum stakeholder input and consultation.

The presentation and meeting lasted an hour. It was chaired by Dr. Steven Beckwith, the Vice President of Research and Graduate Studies at the UC Office of the President.

UAEM communicated detailed responses to some of the committee members’ questions and comments, and it is available here. We also sent a copy of our Frequently Asked Questions , a document that addresses many of the thoughts expressed in the meeting.

Dr. Joel Kirschbaum, UCSF’s head of Technology Management, replied to that letter (his response). Our correspondence with Kirschbaum continues here.